We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$310B
AUM Growth
+$8.85B
Cap. Flow
-$12.9B
Cap. Flow %
-4.15%
Top 10 Hldgs %
14.55%
Holding
10,459
New
1,343
Increased
3,598
Reduced
4,167
Closed
928

Sector Composition

Rank Sector Weight
1 Technology 11.88%
2 Financials 7.38%
3 Consumer Discretionary 6.3%
4 Healthcare 6.09%
5 Communication Services 4.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBP
7051
DELISTED
Urstadt Biddle Properties Inc.
UBP
$27K ﹤0.01%
1,721
+1,106
+180% +$16.7K
ATIP.WS
7052
DELISTED
ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ATIP.WS
$27K ﹤0.01%
+11,723
New +$26.4K
ABB
7053
PUT
DELISTED
ABB Ltd
ABB
$27K ﹤0.01%
+800
New +$26.7K
HCAR
7054
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
$27K ﹤0.01%
2,822
+1,079
+62% +$10.5K
CDR
7055
DELISTED
Cedar Realty Trust, Inc
CDR
$27K ﹤0.01%
1,601
-625
-28% -$9.53K
WEI
7056
DELISTED
Weidai Ltd. American depositary shares, each representing five (5) Class A ordinary shares
WEI
$27K ﹤0.01%
2,979
+2,725
+1,073% +$15.3K
VOSOU
7057
DELISTED
Virtuoso Acquisition Corp. Unit
VOSOU
$27K ﹤0.01%
2,511
+860
+52% +$8.76K
CAHCU
7058
DELISTED
CA Healthcare Acquisition Corp. Unit
CAHCU
$27K ﹤0.01%
+2,590
New +$26.8K
CHIM
7059
DELISTED
Global X MSCI China Materials ETF
CHIM
$27K ﹤0.01%
1,130
+635
+128% +$15.8K
RNWK
7060
DELISTED
RealNetworks Inc
RNWK
$27K ﹤0.01%
11,775
+5,108
+77% +$14.9K
BIS icon
7061
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.18M
$26K ﹤0.01%
710
+709
+70,900% +$30.1K
BOUT icon
7062
CapForce IBD Breakout Opportunities ETF
BOUT
$16.2M
$26K ﹤0.01%
779
-1,201
-61% -$40.2K
BP icon
7063
PUT
BP
BP
$109B
$26K ﹤0.01%
1,000
-99,000
-99% -$2.6M
BQ
7064
Boqii Holding Ltd
BQ
$5.95M
$26K ﹤0.01%
29
+16
+123% +$15K
CTSO icon
7065
Cytosorbents Corp
CTSO
$25M
$26K ﹤0.01%
3,418
-4,164
-55% -$35.1K
DCO icon
7066
Ducommun
DCO
$3.04B
$26K ﹤0.01%
480
-5,807
-92% -$330K
EDUC icon
7067
Educational Development Corp
EDUC
$11.8M
$26K ﹤0.01%
2,100
-266
-11% -$4.09K
ESBA icon
7068
Empire State Realty Series ES
ESBA
$1.37B
$26K ﹤0.01%
2,168
+212
+11% +$2.48K
FDEC icon
7069
FT Vest US Equity Buffer ETF December
FDEC
$1.34B
$26K ﹤0.01%
778
+174
+29% +$5.69K
GROV icon
7070
Grove Collaborative
GROV
$47.1M
$26K ﹤0.01%
+533
New +$26.2K
IRIX icon
7071
IRIDEX
IRIX
$14.6M
$26K ﹤0.01%
3,689
+1,757
+91% +$13.3K
KINS icon
7072
Kingstone Companies
KINS
$301M
$26K ﹤0.01%
3,288
+2,517
+326% +$20.6K
QDEL icon
7073
CALL
QuidelOrtho
QDEL
$1.11B
$26K ﹤0.01%
+200
New +$23.5K
RXRX icon
7074
Recursion Pharmaceuticals
RXRX
$1.69B
$26K ﹤0.01%
+700
New +$20.7K
SMID icon
7075
Smith-Midland
SMID
$149M
$26K ﹤0.01%
+1,100
New +$17.4K

Similar funds

UBS Group's Q2 2021 Portfolio in Review

As of Q2 2021, UBS Group held 10,459 positions worth $310B, up 2.9% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group withdrew a net $12.9B in Q2 2021, closing 928 positions and reducing 4,167 holdings. Its most notable exit was INPHI CORPORATION, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, UBS Group opened a new position in Dimensional US Core Equity 2 ETF worth $42.4M.

  • UBS Group's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 1,571,036 shares worth $42.4M.
  • UBS Group added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $1.02B increase.
  • UBS Group's biggest Q2 2021 reduction was Alibaba, cutting an estimated $2.65B.
  • UBS Group fully exited INPHI CORPORATION in Q2 2021, selling an estimated $121M.
  • UBS Group's ten largest holdings make up 15% of its $310B portfolio in Q2 2021.
  • UBS Group opened 1,343 new positions and closed 928 in Q2 2021.
  • UBS Group's portfolio value rose 2.9% quarter-over-quarter to $310B.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.